Search

Your search keyword '"Kang H. Zheng"' showing total 38 results

Search Constraints

Start Over You searched for: Author "Kang H. Zheng" Remove constraint Author: "Kang H. Zheng"
38 results on '"Kang H. Zheng"'

Search Results

1. First-in-human study of 99mTc-labeled fucoidan, a SPECT tracer targeting P-selectin

2. Lipoprotein(a) Induces Vesicular Cardiovascular Calcification Revealed With Single-Extracellular Vesicle Analysis

Catalog

Books, media, physical & digital resources

3. apoB/apoA‐I Ratio and Lp(a) Associations With Aortic Valve Stenosis Incidence: Insights From the EPIC‐Norfolk Prospective Population Study

4. Lipoprotein(a) is associated with the onset but not the progression of aortic valve calcification

5. Peripheral Ischemia Imprints Epigenetic Changes in Hematopoietic Stem Cells to Propagate Inflammation and Atherosclerosis

6. Comparative in vitro and in vivo Evaluation of Different Iron Oxide-Based Contrast Agents to Promote Clinical Translation in Compliance with Patient Safety

7. Serum Lipoprotein(a) and Bioprosthetic Aortic Valve Degeneration

8. Lipoprotein(a) is robustly associated with aortic valve calcium

9. No benefit of HDL mimetic CER-001 on carotid atherosclerosis in patients with genetically determined very low HDL levels

10. Association of Lipoprotein(a) With Atherosclerotic Plaque Progression

11. Lipoprotein(a) has no major impact on calcification activity in patients with mild to moderate aortic valve stenosis

12. Impact of the B Cell Growth Factor APRIL on the Qualitative and Immunological Characteristics of Atherosclerotic Plaques.

13. Lipoprotein(a) is associated with incidence but not progression of aortic valve calcium

14. Carotid plaque composition in persons with hemophilia

15. Dynamic magnetic resonance measurements of calf muscle oxygenation and energy metabolism in peripheral artery disease

17. Lipoprotein(a) is a strong risk factor for Aortic Valve Calcium

18. Lipoprotein(a) is not associated with active calcification assessed with 18F-NaF PET/CT in patients with mild to moderate aortic valve stenosis

19. Evaluation of ultrasmall superparamagnetic iron-oxide (USPIO) enhanced MRI with ferumoxytol to quantify arterial wall inflammation

20. Quest for pharmacotherapy in aortic valve stenosis: the lipid hypothesis

21. Pathophysiology of Aortic Stenosis and Future Perspectives for Medical Therapy

22. Disease Activity in Mitral Annular Calcification

23. HDL infusion for the management of atherosclerosis: current developments and new directions

24. Lipoprotein(a) is robustly associated with aortic valve calcium.

25. Effects of APOA1, ABCA1 and LCAT mutations on monocyte activation in humans – a double edged sword

26. Plaque Permeability Assessed With DCE-MRI Associates With USPIO Uptake in Patients With Peripheral Artery Disease

27. Lipoprotein(a) and Oxidized Phospholipids Promote Valve Calcification in Patients With Aortic Stenosis

28. P5457Lipoprotein(a) is associated with increased calcification and disease progression in aortic stenosis patients

29. Low Hdl-Cholesterol Levels Are Associated With A Decreased Monocyte Activity And Inflammation In Carriers Of Lcat Mutation

30. Prolonged hematopoietic and myeloid cellular response in patients after an acute coronary syndrome measured with 18F-DPA-714 PET/CT

31. 99Mtc-Fucoidan As Diagnostic Agent For P-Selectin Imaging: First-In-Human Evaluation (Phase I)

33. Liposomal prednisolone promotes macrophage necroptosis in experimental atherosclerosis: does this explain atherogenesis in Cushing's disease?

34. Femoral plaque imaging using ferumoxytol nanoparticles and dynamic contrast-enhanced MRI in patients with peripheral artery disease

35. Prolonged hematopoietic and myeloid cellular response in patients after a myocardial infarction measured with 18F-DPA-714 PET/CT

36. Impact of the B Cell Growth Factor APRIL on the Qualitative and Immunological Characteristics of Atherosclerotic Plaques

37. Sympathetic Neuronal Activation Triggers Myeloid Progenitor Proliferation and Differentiation

38. Increasing B1a lymphocytes through APRIL overexpression in apolipoprotein E-deficient mice stabilizes advanced atherosclerotic lesions by decreasing necrotic area and increasing smooth muscle cell content